TOT BIOPHARM International Company Limited

HKEX:1875.HK

1.74 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q4
Operating Activities:
Net Income 31.559-22.594-15.163-34.192-15.724-146.211-115.005-159.315-129.183-183.614-115.686-74.825-67.066-67.066-67.066-37.172-37.172-37.172
Depreciation & Amortization 30.57124.35617.82718.54117.8817.15615.94515.67315.55313.69813.0896.8383.9143.9143.9143.3743.3743.374
Deferred Income Tax 00042.28600000-6.312.2350000000
Stock Based Compensation 010.643016.11106.15015.832023.5575.8895.8896.4196.4196.4190.0920.0920.092
Change In Working Capital 0-92.5080-40.5890-75.18602.7180-32.066-8.124-8.1245.345.345.34-6.18-6.18-6.18
Accounts Receivables 0-82.5490-36.2780-20.231010.1030-5.10200000000
Change In Inventory 0-31.1880-65.2630-21.44407.1360-12.145-3.036-3.036-0.531-0.531-0.531-0.245-0.245-0.245
Change In Accounts Payables 000000000000000000
Other Working Capital 021.229060.9520-33.5110-14.5210-14.819-5.088-5.0885.8715.8715.871-5.935-5.935-5.935
Other Non Cash Items -34.32974.12159.74971.20626.696116.5785.436-31.0766.68251.062-21.3697.397.1857.1857.18510.53910.53910.539
Operating Cash Flow 27.801-5.98262.41331.07728.852-81.513-93.624-156.168-106.948-127.363-123.966-62.832-44.208-44.208-44.208-29.347-29.347-29.347
Investing Activities:
Investments In Property Plant And Equipment -68.853-71.505-125.776-181.108-57.872-57.143-55.146.69-27.177-19.275-17.011-9.335-19.55-19.55-19.55-33.671-33.671-33.671
Acquisitions Net 00-3.8180.0940000003.4450000000
Purchases Of Investments 00-320.06-279.91000000-32.95-32.95-29.125-29.125-29.125-15.075-15.075-15.075
Sales Maturities Of Investments 00366.672241.95800000029.50529.50536.90836.90836.90821.00721.00721.007
Other Investing Activites 0.069-7.85241.028-38.245-5.5394.26-0.37241.627-208.614-3.98-10.83612.7811.76711.76711.76727.73927.73927.739
Investing Cash Flow -68.784-79.357-84.748-219.353-63.411-52.883-55.51248.317-235.791-23.255-27.847-12.78-11.767-11.767-11.767-27.739-27.739-27.739
Financing Activities:
Debt Repayment 37.739039.645037.994071.3270-61.180-1.0740000000
Common Stock Issued 000453.984000000135.488135.488000000
Common Stock Repurchased 000000000000000000
Dividends Paid 000000000000000000
Other Financing Activities -1.534.14-5.56447.857-4.611131.1459.6117.692-18.219529.21154.885131.151-17.4117.048-17.41000
Financing Cash Flow 36.2094.1434.085447.85733.383131.14580.93717.692-79.399529.21153.811131.151-17.41-17.41-17.41000
Other Information:
Effect Of Forex Changes On Cash 1.524-0.1763.4563.3123.247-0.187-1.0932.183-3.5333.453-1.61515.069131.427131.427131.427000
Net Change In Cash -3.250-39.437317.5362.071-3.438-69.29112.024-425.671382.04692.94670.60758.04358.04358.0431.1341.1341.134
Cash At End Of Period 348.35432.975432.975472.412154.876152.805156.243225.533113.509539.18157.134134.79564.18864.18864.1886.1456.1456.145